Pace Surgical appears in the linked FDA records as the applicant on two premarket notifications for foot and ankle fixation hardware, both reviewed by the Orthopedic panel and classified as Class II under 21 CFR 888.3030. The company's own website describes it as founded to create anatomically specific foot and ankle trauma and reconstruction solutions designed by surgeons, and names its Ultra Compression Screw System and Tempo Variable Locking Plating technologies. The filings and the company's published description are the documented basis for this profile; ownership, headquarters and commercial reach are not established by the public information. [1][2][5]
Two cleared plating and screw submissions
The supplied collection holds two 510(k) records, both with a substantially equivalent decision, and the smaller record sample contains the same two entries. K261647 covers the Tempo Plating System and Ultra Compression Screw System, was received May 19, 2026, and was decided September 3, 2026 as a Traditional submission. K263407 covers the Tempo Plating System, was received September 25, 2026, and was decided October 23, 2026 as a Special submission. Both name Pace Surgical as applicant and carry product code HRS. [1][2][4]
The K261647 clearance letter lists regulation number 21 CFR 888.3030, regulation name Single/Multiple Component Metallic Bone Fixation Appliances and Accessories, Class II, and product codes HRS and HWC. It states that the subject plates demonstrated substantially equivalent performance to the predicate plates in mechanical testing, and concludes equivalence to predicate devices K250952, K251555 and K203011. [4]
What the devices are documented to cover
A device summary for K263407 describes the Tempo Plating System as indicated for stabilization and fixation of fractures or osteotomies, including intra- and extra-articular fractures and joint depression. The same summary lists bones of the feet, including toes, midfoot and hindfoot (talus and calcaneus), and the ankle, with examples such as Lapidus fusion of the first metatarsal-cuneiform joint, metatarsal or phalangeal fractures and osteotomies, lesser metatarsal fractures and fifth metatarsal fractures. [9][10]
That summary states the subject devices are considered substantially equivalent to predicate devices K261647 and K250952. The FDA record for K263407 lists the device classification name as Plate, Fixation, Bone, device class 2, regulation 888.3030, review panel Orthopedic, and a Summary statement or summary. [8][9]
Company description and attribution
Pace Surgical's website states the company was founded to create anatomically specific foot and ankle trauma and reconstruction solutions designed by surgeons, and that its Ultra Compression Screw System and Tempo Variable Locking Plating technologies set a new standard in foot and ankle trauma care. The site also describes products as low profile and designed with patient comfort in mind. These are the company's own published characterizations, not independently verified findings. [5]
The FDA filings list a Malvern, Pennsylvania address for the applicant, and the K261647 letter is addressed to Pace Surgical care of a regulatory consultant at MRC Global, LLC in Lakeland, Tennessee. A filing address is not evidence of a headquarters location, and the public information does not identify ownership, a parent company or a brand hierarchy. [1][4]
How to read the collection
The two records and two substantially equivalent decisions describe the supplied filings as of the snapshot date; they are not a measure of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. The K263407 record appears in FDA-derived indexes with matching applicant, product code, decision and dates, which is consistent with the openFDA entry. [1][2][8]

